RAP 0.00% 20.5¢ resapp health limited

Ann: ResApp Provides Update on SMARTCOUGH-C-2 Study Timing, page-2

  1. 4,843 Posts.
    lightbulb Created with Sketch. 2370
    ResApp’s contracted Clinical Research Organisation and the site Principal Investigators have notified the Company that adjudication is progressing well and that based on the projected availability of adjudicators it will be approximately two weeks before the data is un-blinded and preliminary top-line results are delivered.
 
watchlist Created with Sketch. Add RAP (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.